Carroll P - Search Results

1

Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS Cohort.

Waisman Malaret AJ, Chang P, Zhu K, Zheng Y, Newcomb LF, Liu M, McKenney JK, Brooks JD, Carroll P, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Nelson PS, Lin DW, Wagner AA. Waisman Malaret AJ, et al. Among authors: carroll p. J Urol. 2022 Apr;207(4):805-813. doi: 10.1097/JU.0000000000002354. Epub 2021 Dec 2. J Urol. 2022. PMID: 34854745 Free PMC article.

2

The value of prostate specific antigen and transrectal ultrasound guided biopsy in detecting prostatic fossa recurrences following radical prostatectomy.

Foster LS, Jajodia P, Fournier G Jr, Shinohara K, Carroll P, Narayan P. Foster LS, et al. Among authors: carroll p. J Urol. 1993 May;149(5):1024-8. doi: 10.1016/s0022-5347(17)36287-0. J Urol. 1993. PMID: 7683341

3

Primary osteogenic sarcoma of the urinary bladder successfully treated with combination therapy.

Phan CN, Wilkinson M, Cohen MB, Dunn S, Carroll P. Phan CN, et al. Among authors: carroll p. Urology. 1994 Nov;44(5):771-4. doi: 10.1016/s0090-4295(94)80228-9. Urology. 1994. PMID: 7974956

4

Radiotherapy for high grade clinically localized adenocarcinoma of the prostate.

Roach M 3rd, Meehan S, Kroll S, Weil M, Ryu J, Small EJ, Margolis LW, Presti J, Carroll PC, Phillips TL. Roach M 3rd, et al. Among authors: carroll pc. J Urol. 1996 Nov;156(5):1719-23. J Urol. 1996. PMID: 8863578 Clinical Trial.

5

Deletion of Y-chromosome specific genes in human prostate cancer.

Perinchery G, Sasaki M, Angan A, Kumar V, Carroll P, Dahiya R. Perinchery G, et al. Among authors: carroll p. J Urol. 2000 Apr;163(4):1339-42. J Urol. 2000. PMID: 10737540

6

Prostate-specific antigen best practice policy--part I: early detection and diagnosis of prostate cancer.

Carroll P, Coley C, McLeod D, Schellhammer P, Sweat G, Wasson J, Zietman A, Thompson I. Carroll P, et al. Urology. 2001 Feb;57(2):217-24. doi: 10.1016/s0090-4295(00)00993-6. Urology. 2001. PMID: 11182324 No abstract available.

7

Prostate-specific antigen best practice policy--part II: prostate cancer staging and post-treatment follow-up.

Carroll P, Coley C, McLeod D, Schellhammer P, Sweat G, Wasson J, Zietman A, Thompson I. Carroll P, et al. Urology. 2001 Feb;57(2):225-9. doi: 10.1016/s0090-4295(00)00994-8. Urology. 2001. PMID: 11182325 Review. No abstract available.

8

Methylation of the E-cadherin gene promoter correlates with progression of prostate cancer.

Li LC, Zhao H, Nakajima K, Oh BR, Ribeiro Filho LA, Carroll P, Dahiya R. Li LC, et al. Among authors: carroll p. J Urol. 2001 Aug;166(2):705-9. J Urol. 2001. PMID: 11458121

9

Rising PSA after a radical treatment.

Carroll P. Carroll P. Eur Urol. 2001;40 Suppl 2:9-16. doi: 10.1159/000049879. Eur Urol. 2001. PMID: 11684859 Review.

10

Lifestyle and health-related quality of life of men with prostate cancer managed with active surveillance.

Daubenmier JJ, Weidner G, Marlin R, Crutchfield L, Dunn-Emke S, Chi C, Gao B, Carroll P, Ornish D. Daubenmier JJ, et al. Among authors: carroll p. Urology. 2006 Jan;67(1):125-30. doi: 10.1016/j.urology.2005.07.056. Urology. 2006. PMID: 16413347 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,088 results

Search Page

Filters